RNA Expression Levels from Peripheral Immune Cells, a Minimally Invasive Liquid Biopsy Source to Predict Response to Therapy, Survival and Immune-Related Adverse Events in Patients with Triple Negative Breast Cancer Enrolled in the GeparNuevo Trial.
JOURNAL OF CLINICAL ONCOLOGY（2023）
关键词
Tumor Microenvironment,Biomarkers for Immunotherapy,RNA-sequencing
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要